The Role of Bioactive Peptides in Diabetes and Obesity.
Ramachandran ChelliahShuai WeiEric Banan-Mwine DaliriFazle ElahiSu-Jung YeonAkanksha TyagiShucheng LiuInamul Hasan MadarGhazala SultanDeog- Hwan OhPublished in: Foods (Basel, Switzerland) (2021)
Bioactive peptides are present in most soy products and eggs and have essential protective functions. Infection is a core feature of innate immunity that affects blood pressure and the glucose level, and ageing can be delayed by killing senescent cells. Food also encrypts bioactive peptides and protein sequences produced through proteolysis or food processing. Unique food protein fragments can improve human health and avoid metabolic diseases, inflammation, hypertension, obesity, and diabetes mellitus. This review focuses on drug targets and fundamental mechanisms of bioactive peptides on metabolic syndromes, namely obesity and type 2 diabetes, to provide new ideas and knowledge on the ability of bioactive peptide to control metabolic syndromes.
Keyphrases
- type diabetes
- human health
- insulin resistance
- blood pressure
- amino acid
- risk assessment
- glycemic control
- metabolic syndrome
- weight loss
- high fat diet induced
- cardiovascular disease
- weight gain
- climate change
- healthcare
- induced apoptosis
- protein protein
- blood glucose
- oxidative stress
- adipose tissue
- tissue engineering
- cell proliferation
- small molecule
- body mass index
- deep learning
- binding protein
- heart rate
- hypertensive patients
- skeletal muscle
- endoplasmic reticulum stress
- adverse drug